ISO 11608: Needle-Based Injection Systems for Medical Use
1. Principles and Scope
1.1 Description and Field of Application
ISO 11608 is a multi-part standard defining technical requirements for needle-based injection systems intended for medical administration. The standard covers the following elements:
- Part 1: Requirements and test methods (pen injectors)
- Part 2: Needles
- Part 3: Finished containers
- Part 4: Electronic and electromechanical systems
- Part 5: Automated functions
- Part 7: Accessibility
The standard applies to disposable or reusable pen injectors delivering measured doses of medicaments via subcutaneous route.
1.2 Comparisons with Related Standards
| Standard | Field | Relationship |
|---|---|---|
| ISO 11040 | Prefilled syringes | ISO 11608 uses ISO 11040 cartridges as primary container |
| IEC 62366-1 | Usability engineering | Requirements for ergonomics and ease of use of pens |
| ISO 23908 | Sharps injury protection | Needle safety devices after injection |
| ISO 10993 | Biocompatibility | Assessment of components contacting medicament or skin |
2. Role and Importance
2.1 Primary Objective
ISO 11608 ensures the reliability, accuracy, and safety of pen injector systems used for administration of innovative therapies. These devices are essential for patients requiring regular self-injection and must provide a safe and reproducible user experience.
2.2 Quality Control and Compliance
Manufacturers of pen injectors must demonstrate compliance through:
- Dose accuracy testing (±10% tolerance typically)
- Mechanical durability testing (multiple pressure cycles)
- Container seal integrity testing
- Flow rate and delivery testing
- Needle safety and sharps protection testing
- Usability testing with actual users
- Electronic system testing (if applicable)
2.3 Limitations and Scope
ISO 11608 does not cover:
- Conventional syringes without integrated mechanical systems
- Direct intramuscular or intravenous injections
- Infusion pumps or perfusion devices
Important Note: ISO 11608-4 and 11608-5 cover electronic and automated functions (dose memory, alarms, connectivity), becoming critical for modern data-driven therapies.
3. Procedures and Technical Requirements
3.1 Dose Accuracy and Repeatability
Critical requirements per ISO 11608-1:
- Delivery accuracy ±10% of designated dose (or stricter if contractualized)
- Repeatability over minimum 100 doses
- Stability under storage and transport conditions
- Performance at extreme temperatures (4-40°C typically)
3.2 Mechanical Design and Service Life
The pen must support:
- A minimum number of injections (100+ cycles typically)
- Accidental drops (robustness testing)
- Mechanical wear of moving components
- Handling pressure (actuation force controlled)
3.3 Needle Safety and Protection
Mandatory protection per ISO 11608-2 and ISO 23908:
- Automatic needle shielding after injection
- Locking mechanism preventing re-injection
- Protection against accidental needle sticks during handling
- Visibility of needle stage (complete retraction verifiable)
3.4 Electronic and Connectivity Systems
For ISO 11608-4 and 11608-5 (where applicable):
- Battery / energy source durable over device life
- Certified software and dose delivery verification
- Electronic locking mechanism against excessive doses
- Memory of previous doses (history)
- Alarms and malfunction notifications
- Cybersecurity (if connected)
3.5 Usability and Accessibility
Requirements per ISO 11608-7 and IEC 62366-1:
- Intuitive user interface without extensive training
- Buttons and controls accessible for aging populations
- Clear instructions and multilingual labeling
- User feedback (visual, auditory, or tactile)
- Accessibility for persons with disabilities
4. Regulatory Framework and Applications
4.1 Regulatory References
ISO 11608 is referenced by:
- Directive 2017/745/EU (MDR): Medical device conformity
- Directive 2014/30/EU: Electromagnetic compatibility (if applicable)
- FDA guidance: American equivalent for approvals
- IEC 60601 standard: Electrical safety (for electronic systems)
4.2 Sectoral Applications
Insulin Therapy
Insulin pen injectors for type 1 and 2 diabetes. Critical accuracy ±10% for stable blood glucose. Reusable devices with interchangeable ISO 11040 cartridges.
GLP-1 Agonists
Pens for semaglutide, tirzepatide and others. Weekly or bi-weekly injections. Electronic systems for dose interval management.
Growth Hormone
Pens for somatotropin, LH, FSH. Precise doses for pediatric and adult populations. Pediatric design with reinforced needle safety.
Biotherapeutics and Immunomodulators
Pens for monoclonal antibodies, biological factors. Advanced systems with dose memory and connectivity for therapeutic monitoring.
5. Best Practices
5.1 For Pen Injector Manufacturers
- Design according to ISO 11608 from initial sketch phase
- Conduct early usability studies with target patient populations
- Validate dose accuracy with robust statistical testing
- Test mechanical compatibility with intended ISO 11040 cartridges
- Implement durability testing representing real-world life
- Comprehensively document test results for conformity dossiers
- Train teams on usability and accessibility requirements
5.2 For Pharmaceutical Manufacturers and Regulatory Authorities
- Require comprehensive ISO 11608 test list from pen supplier
- Evaluate usability in marketing authorization dossiers (IEC 62366 compliance)
- Verify medicament-device compatibility (physical and chemical interaction)
- Audit pen manufacturers on ISO 11608 test protocols
- Maintain post-market pharmacovigilance program specific to injection malfunctions
- Adapt instructions for specific populations (age, disability)